The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness

P<sub>53 </sub>tumor suppressor gene mutation is one of the most common genetic alteration in human malignancies. This study was done to determine the prevalence of the P<sub>53 </sub>antigen expression by sex, age, type of melanoma, thickness of the lesion and site of the an...

Full description

Bibliographic Details
Main Authors: Faghihi Gita, Radan Mohammadreza, Ghanei Narges, Rajabi Parvin, Taheri Diana
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2005-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2005;volume=50;issue=3;spage=133;epage=135;aulast=Faghihi
id doaj-6b35b3bd2863401a92db1207ba156133
record_format Article
spelling doaj-6b35b3bd2863401a92db1207ba1561332020-11-24T23:01:04ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51542005-01-01503133135The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thicknessFaghihi GitaRadan MohammadrezaGhanei NargesRajabi ParvinTaheri DianaP<sub>53 </sub>tumor suppressor gene mutation is one of the most common genetic alteration in human malignancies. This study was done to determine the prevalence of the P<sub>53 </sub>antigen expression by sex, age, type of melanoma, thickness of the lesion and site of the antigen expression either cytoplasmic or nuclear.<i> </i> Paraffin embeded block of 50 patients (45 primary and metastatic)with documented diagnosis of melanoma deparaffinized and immuno stained with DO-7 monoclonal antibody. The lesions were divided depending on the degree of the staining as follow: 1. no staining, 2. mild (less than 10&#x0025;), 3. moderate (10&#x0025;-50&#x0025; staining), 4. severe (more than 50&#x0025;). Fifty four percent of evaluated patients were female and 46&#x0025; were male. Forty percent of lesions were graded as no staining, 36&#x0025; of lesions showed mild staining, 14&#x0025; moderate and 10&#x0025; severe staining site of expression was excusively in the cytoplasm. There was no meaningful statistical deference between severity of staining and the age group, sex, type and thickness of melanoma. (p value was 0.532, 0.488, 0.626, 0.954 respectively). http://www.e-ijd.org/article.asp?issn=0019-5154;year=2005;volume=50;issue=3;spage=133;epage=135;aulast=FaghihiMelanomaP<sub>53 </sub>antigen
collection DOAJ
language English
format Article
sources DOAJ
author Faghihi Gita
Radan Mohammadreza
Ghanei Narges
Rajabi Parvin
Taheri Diana
spellingShingle Faghihi Gita
Radan Mohammadreza
Ghanei Narges
Rajabi Parvin
Taheri Diana
The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thickness
Indian Journal of Dermatology
Melanoma
P<sub>53 </sub>antigen
author_facet Faghihi Gita
Radan Mohammadreza
Ghanei Narges
Rajabi Parvin
Taheri Diana
author_sort Faghihi Gita
title The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thickness
title_short The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thickness
title_full The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thickness
title_fullStr The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thickness
title_full_unstemmed The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thickness
title_sort evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it&#x2032;s relation to tumor thickness
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Dermatology
issn 0019-5154
publishDate 2005-01-01
description P<sub>53 </sub>tumor suppressor gene mutation is one of the most common genetic alteration in human malignancies. This study was done to determine the prevalence of the P<sub>53 </sub>antigen expression by sex, age, type of melanoma, thickness of the lesion and site of the antigen expression either cytoplasmic or nuclear.<i> </i> Paraffin embeded block of 50 patients (45 primary and metastatic)with documented diagnosis of melanoma deparaffinized and immuno stained with DO-7 monoclonal antibody. The lesions were divided depending on the degree of the staining as follow: 1. no staining, 2. mild (less than 10&#x0025;), 3. moderate (10&#x0025;-50&#x0025; staining), 4. severe (more than 50&#x0025;). Fifty four percent of evaluated patients were female and 46&#x0025; were male. Forty percent of lesions were graded as no staining, 36&#x0025; of lesions showed mild staining, 14&#x0025; moderate and 10&#x0025; severe staining site of expression was excusively in the cytoplasm. There was no meaningful statistical deference between severity of staining and the age group, sex, type and thickness of melanoma. (p value was 0.532, 0.488, 0.626, 0.954 respectively).
topic Melanoma
P<sub>53 </sub>antigen
url http://www.e-ijd.org/article.asp?issn=0019-5154;year=2005;volume=50;issue=3;spage=133;epage=135;aulast=Faghihi
work_keys_str_mv AT faghihigita theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT radanmohammadreza theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT ghaneinarges theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT rajabiparvin theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT taheridiana theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT faghihigita evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT radanmohammadreza evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT ghaneinarges evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT rajabiparvin evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
AT taheridiana evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness
_version_ 1725640790426779648